(Q44535163)

English

Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori

scientific article published in August 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

antimicrobial resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Chi CH

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Lin CY

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sheu BS

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Yang HB

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Huang AH

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Wu JJ

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

347-353

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

The Treatment ofHelicobacter pyloriInfection in the Management of Peptic Ulcer Disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Helicobacter pylori-related disease: guidelines for testing and treatment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Efficacy of a multistep strategy for Helicobacter pylori eradication.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Quadruple treatments for Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Helicobacter pylori: the challenge in therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Selection of lower cutoff point of [13C]urea breath test is helpful to monitor H. pylori eradication after proton pump inhibitor-based triple therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Stool antigen assay to screen H. pylori infection and to assess the success of 3-Day and 7-Day eradication therapy in the patients with partial gastrectomy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01653.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2003.01653.X

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44535163&oldid=2027058158"